• This workshop provides an overview of AI Foundry and Co-Pilot capabilities, demonstrating
how these tools support the development and orchestration of agentic AI systems through
practical, hands-on examples.
• Demonstrates core features of AI Foundry for scalable AI model development and
deployment, enabling autonomous agent behavior in complex workflows.
• Explores Co-Pilot integration to enhance developer productivity with AI-assisted coding
and automation, facilitating multi-agent collaboration and decision-making.
• Walks participants through real-world scenarios showcasing AI Foundry and Co-Pilot in
action, highlighting their role in building and managing agentic AI systems.
Daniel Hulme, Chief AI Officer, WPP, Room Universe
• In a world where many believe access to more and more data will lead to ever better decision-making, we’ll look at what AI really is - Identifying the current and future challenges and opportunities for emerging technologies
• New framework for thinking about AI, and discussion on how organisations can practically adopt these technologies and avoid being seduced by the hype
• Whilst these technologies are incredible at creating growth and streamlining operations, for companies to stay innovative they need to also use AI to unlock the creative capacity of their workforce.
• Macro impact these technologies may have on business and humanity over the coming decades
• Definition of intelligence and decision-making in the context of AI, questioning the
assumption that more data automatically leads to better outcomes
• Application of agentic systems to augment human creativity, enable adaptive operations,
and support long-term innovation across sectors.
• Assessment of AI’s broader impact on society, governance, and human agency over the
coming decades, including ethical and economic implications
• How open-source foundation models can be securely adapted and fine-tuned for real-
world business use cases.
• Insights into model versioning, access control, and performance tracking as enablers of
responsible AI deployment at scale.
• Examples from enterprise projects that combine modular tooling, community-driven
innovation, and production-grade workflows.
Reserved for one of our business Partners
• Exploring fundamental technical aspects of AI agents, including core capabilities and
architectures enabling agentic behavior.
• Discussing multi-agent systems with collaborative and competitive AI agents pursuing
shared objectives, and their superior use cases.
• Highlighting challenges in deploying multi-agent systems, such as error amplification and
suboptimal system behavior, and implications for business users.
• How autonomous agents are being integrated into engineering workflows across the
product lifecycle, supply-chain, purchasing and manufacturing operations.
• Use cases for AI in product life cycle (PLM) systems and within design teams.
• Breaking silos in manufacturing and using agents to unite the path from design phase to
final customer experience
• How leading enterprises restructure around GenAI — from AI product owners to prompt
engineers and data domain stewards.
• Explore federated vs. centralized approaches, business-user enablement, and lessons in
cultural transformation.
• Insights into how new team structures align with regulatory expectations and support
scalable, cross-functional AI deployment.
• Showcasing real-world applications of agentic AI across automotive, pharma, finance,
and insurance sectors.
• Examining how enterprises structure secure, compliant multi-agent systems using
frameworks like Semantic Kernel and Autogen.
• Reviewing evaluation strategies for GenAI quality and responsible AI design under evolving
regulatory expectations.
• How agentic workflows and no-/low-code platforms enable
business users to design AI-powered automations without full
developer dependency.
• Highlights the organizational challenge of balancing creative
freedom with compliance, quality control, and long-term
maintainability.
• Early lessons from deploying visual orchestration tools
for internal operations, with a view toward secure external
applications.
• Define which roles across business and tech functions need
• AI-related upskilling, and to what depth.
• Compare centralized vs. decentralized models for both GenAI
• implementation and capability building.
• Clarify how headquarters and local entities split responsibility
• for enablement, innovation, and compliance.
Slot reserved for one of our business partners
• Exploration of AI-driven change management techniques to
enhance operational excellence.
• Use of AI for strategic decision-making, including predicting
and managing change impacts.
• Automation of routine processes to increase productivity and
streamline organizational transformation.
• Showcases real-world applications of agentic AI to optimize
pharma and biopharma manufacturing processes.
• Explores autonomous agents for predictive maintenance,
quality control, and supply chain coordination.
• Highlights challenges and solutions in deploying agentic
systems within highly regulated manufacturing environments.
Ogsen Gabrielyan - Head of Data Science in the Global Engineering & Technology, Boehringer Ingelheim Biopharmaceuticals• How GenAI transformed our R&D Risk and knowledge
management by introducing our R&D chatbot “nexi”
• A solution built for 120 R&D specialists iand its integration into
a global IT AI strategy for a >10.000 employee company.
• Lessons learned and how we are approaching challenges
like organizational boundaries, resource and competence
constraints, accuracy, relevance, hallucination, speed, AI
adoption in the teams and balancing the AI hype within the
company
• Application of a signal-native generative model that
transforms magnetic and ultrasonic waveforms into 3D
corrosion and wall-thickness profiles for infrastructure like
pipelines and pressurized vessels.
• Integration of synthetic signal generation and simulation-
trained embeddings to overcome data scarcity, reduce expert
dependency, and deliver explainable, regulation-aligned output.
• Future potential for adapting the same architecture to other
signal-rich domains such as medical diagnostics, where real
data is scarce, and model bias must be minimized from the start
• Why multi-agent systems are critical for complex, creative
tasks beyond the reach of single LLMs
• The architectural trade-offs: centralized vs. decentralized,
freedom vs. structure
• Examples from real-world cooperative agent + human
systems and upcoming frameworks
• Use of labeling platforms, entity recognition, and relationship
extraction tools to convert PDFs, emails, and legacy wikis into
structured knowledge graphs.
• Integration of curated knowledge into chatbots, copilots, and
decision support tools for employees and customers.
• Scaling annotation with human-in-the-loop QA and
alignment with business taxonomies and security controls
• Use of vector databases and semantic chunking to build RAG
pipelines that deliver accurate, explainable outputs in legal,
tech, and service use cases.
• Architecture patterns for combining public LLMs with private
corpora using on-prem, hybrid, or sovereign infrastructure.
• Governance of document updates, access control, and
hallucination risk mitigation in production RAG deployments.
• Addressing knowledge loss from workforce turnover by using
LLM-powered systems to support onboarding and reduce
training dependency on senior experts
• Deployment of retrieval-augmented generation using vector
databases to enable natural language queries across internal
documentation
• Managing inconsistencies in source material through
AI-supported synthesis and contextual reasoning across
fragmented content sets
• Preparing and formatting internal content for AI systems
• Challenges with hallucinations and prompt tuning
• Demonstrating ROI and ongoing optimization of GenAI tools
• How generative AI can address foundational challenges
in healthcare AI, including limited labeled data, and privacy
constraints
• The potential of synthetic medical images to support fairer,
more generalizable models and improve diagnostic workflows
in radiology and oncology
• Current limitations and open challenges in evaluating
generative models, including clinical relevance, realism, and
unintended artifacts
• Quality of life is a complex, multidimensional concept that is
difficult to continuously measure using conventional methods.
• Vocal biomarkers offer a promising alternative because
voice production is highly complex and sensitive to changes in
physical and mental health.
• A machine learning model was developed to analyze vocal
characteristics and objectively assess quality of life.
• Due to the complex data structure, a quantum-based
machine learning model was also investigated to capture
deeper patterns.
• Use of generative models to create brand-consistent
imagery across marketing, ecommerce, and documentation
workflows.
• Deployment of controlled image generation pipelines
using structured prompts, visual references, and predefined
templates to reduce reliance on stock photography.
• Integration with human review, metadata tagging, and digital
asset management systems to maintain aesthetic coherence,
IP safety, and regulatory alignment.
• Use of agentic AI systems to generate explainer videos,
training content, and product walkthroughs by combining
narration, imagery, and animation in real time.
• Chaining of LLMs, text-to-video models, and editing tools to
produce scene-structured outputs based on user intent and
enterprise knowledge.
• Incorporation of brand rules, compliance filters, and
multilingual adaptation to support global scalability and
internal reuse.